Select Publications
Journal articles
2017, 'Non-steroidal anti-inflammatory drugs for spinal pain: A systematic review and meta-analysis', Annals of the Rheumatic Diseases, 76, pp. 1269 - 1278, http://dx.doi.org/10.1136/annrheumdis-2016-210597
,2017, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration (vol 68, pg 990, 2016)', AMERICAN JOURNAL OF KIDNEY DISEASES, 69, pp. 870 - 870, http://dx.doi.org/10.1053/j.ajkd.2017.03.016
,2017, 'Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat', Clinical Pharmacokinetics, 56, pp. 459 - 475, http://dx.doi.org/10.1007/s40262-016-0466-4
,2017, 'Introduction to the Special Section: Phase I Clinical Trials', Therapeutic Innovation and Regulatory Science, 51, pp. 274 - 275, http://dx.doi.org/10.1177/2168479017706513
,2017, 'Life-threatening drug interactions: what the physician needs to know', Internal Medicine Journal, 47, pp. 501 - 512, http://dx.doi.org/10.1111/imj.13404
,2017, 'Allopurinol: insights from studies of dose–response relationships', Expert Opinion on Drug Metabolism and Toxicology, 13, pp. 449 - 462, http://dx.doi.org/10.1080/17425255.2017.1269745
,2017, 'Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries', The Lancet, 389, pp. 1268 - 1272, http://dx.doi.org/10.1016/S0140-6736(16)32051-7
,2017, 'A systems science perspective on the capacity for change in public hospitals', Israel Journal of Health Policy Research, 6, http://dx.doi.org/10.1186/s13584-017-0143-6
,2017, 'Trial of pregabalin for acute and chronic sciatica', New England Journal of Medicine, 376, pp. 1111 - 1120, http://dx.doi.org/10.1056/NEJMoa1614292
,2017, 'Automation bias in electronic prescribing', BMC Medical Informatics and Decision Making, 17, http://dx.doi.org/10.1186/s12911-017-0425-5
,2017, 'Alert override as a habitual behavior - A new perspective on a persistent problem', Journal of the American Medical Informatics Association, 24, pp. 409 - 412, http://dx.doi.org/10.1093/jamia/ocw072
,2017, 'Feedback and training to improve use of an electronic prescribing system: A randomised controlled trial', Studies in Health Technology and Informatics, 239, pp. 63 - 69, http://dx.doi.org/10.3233/978-1-61499-783-2-63
,2017, 'Individualising the dose of allopurinol in patients with gout', British Journal of Clinical Pharmacology, 83, pp. 2015 - 2026, http://dx.doi.org/10.1111/bcp.13307
,2017, 'Redesign of computerized decision support to improve antimicrobial prescribing', Applied Clinical Informatics, 8, pp. 949 - 963, http://dx.doi.org/10.4338/ACI2017040069
,2017, 'Erratum: Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum].', Drug Des Devel Ther, 11, pp. 3589 - 3590, http://dx.doi.org/10.2147/DDDT.S158965
2017, 'The impact of serious adverse drug reactions: a population‐based study of a decade of hospital admissions in New South Wales, Australia', British journal of clinical pharmacology, 83, pp. 416 - 426
,2016, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration', American Journal of Kidney Diseases, 68, pp. 990 - 992, http://dx.doi.org/10.1053/j.ajkd.2016.08.017
,2016, 'Potentially inappropriate medications (PIMs) in older hospital in-patients: Prevalence, contribution to hospital admission and documentation of rationale for continuation', Australasian Journal on Ageing, 35, pp. 262 - 265, http://dx.doi.org/10.1111/ajag.12312
,2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y
,2016, 'Ganciclovir - Hypoglycaemia', WHO SIGNAL, pp. 15 - 18
,2016, 'Mobile applications to enhance self-management of gout', International Journal of Medical Informatics, 94, pp. 67 - 74, http://dx.doi.org/10.1016/j.ijmedinf.2016.06.021
,2016, 'Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: A study protocol', BMJ Open, 6, http://dx.doi.org/10.1136/bmjopen-2016-011811
,2016, 'Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinine', Clinical Rheumatology, 35, pp. 2375 - 2376, http://dx.doi.org/10.1007/s10067-015-3165-x
,2016, 'Severe GHB withdrawal delirium managed with dexmedetomidine', Medical Journal of Australia, 205, pp. 251 - 252.e1, http://dx.doi.org/10.5694/MJA16.00269
,2016, 'OPAL: A randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol', BMJ Open, 6, http://dx.doi.org/10.1136/bmjopen-2016-011278
,2016, 'The effectiveness of information technology to improve antimicrobial prescribing in hospitals: A systematic review and meta-analysis', International Journal of Medical Informatics, 92, pp. 15 - 34, http://dx.doi.org/10.1016/j.ijmedinf.2016.04.008
,2016, 'A time and motion study of junior doctor work patterns on the weekend: a potential contributor to the weekend effect?', Internal Medicine Journal, 46, pp. 819 - 825, http://dx.doi.org/10.1111/imj.13120
,2016, 'Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain a systematic review and meta-analysis', JAMA Internal Medicine, 176, pp. 958 - 968, http://dx.doi.org/10.1001/jamainternmed.2016.1251
,2016, 'Evaluation of hospital-wide computerised decision support in an intensive care unit: An observational study', Anaesthesia and Intensive Care, 44, pp. 507 - 512, http://dx.doi.org/10.1177/0310057x1604400403
,2016, 'Exploring sub-optimal use of an electronic risk assessment tool for venous thromboembolism', Applied Ergonomics, 55, pp. 63 - 69, http://dx.doi.org/10.1016/j.apergo.2016.01.003
,2016, 'Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate', Annals of the Rheumatic Diseases, 75, pp. 1363 - 1366, http://dx.doi.org/10.1136/annrheumdis-2015-208111
,2016, 'Where to find information about drugs', Australian Prescriber, 39, pp. 88 - 95, http://dx.doi.org/10.18773/austprescr.2016.023
,2016, 'Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises', Arthritis Care and Research, 68, pp. 667 - 672, http://dx.doi.org/10.1002/acr.22741
,2016, 'Allopurinol dose relative to renal function and risk of hypersensitivity reactions', Annals of the Rheumatic Diseases, 75, pp. e21, http://dx.doi.org/10.1136/annrheumdis-2015-209109
,2016, 'Allopurinol hypersensitivity: Investigating the cause and minimizing the risk', Nature Reviews Rheumatology, 12, pp. 235 - 242, http://dx.doi.org/10.1038/nrrheum.2015.132
,2016, 'Drug checking to improve monitoring of new psychoactive substances in Australia Drug checking may need to play a part in future public health interventions', MEDICAL JOURNAL OF AUSTRALIA, 204, pp. 144 - +, http://dx.doi.org/10.5694/mja15.01058
,2016, 'Achieving the World Health Organization's vision for clinical pharmacology', British journal of clinical pharmacology, 81, pp. 223 - 227, http://dx.doi.org/10.1111/bcp.12803
,2016, 'PRECISE - pregabalin in addition to usual care: Statistical analysis plan', Trials, 17, http://dx.doi.org/10.1186/s13063-016-1174-y
,2016, 'A user-centred approach to designing an etool for gout management', Studies in Health Technology and Informatics, 227, pp. 28 - 33, http://dx.doi.org/10.3233/978-1-61499-666-8-28
,2016, 'Barriers to care in gout: From prescriber to patient', Journal of Rheumatology, 43, pp. 144 - 149, http://dx.doi.org/10.3899/jrheum.150607
,2016, 'The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', ANTIVIRAL THERAPY, 21, pp. 127 - 132, http://dx.doi.org/10.3851/IMP2984
,2016, 'The toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and polynesian sample sets', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0147939
,2016, 'Xanthine oxidoreductase and its inhibitors: Relevance for gout', Clinical Science, 130, pp. 2167 - 2180, http://dx.doi.org/10.1042/CS20160010
,2016, 'Barriers to the treatment of gout: a community pharmacy perspective', Research in Social and Administrative Pharmacy, 12, pp. e31 - e31, http://dx.doi.org/10.1016/j.sapharm.2016.05.077
,2016, 'Real-time prediction of mortality, readmission, and length of stay using electronic health record data', Journal of the American Medical Informatics Association, 23, pp. 553 - 561
,2015, 'Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin', Annals of the Rheumatic Diseases, 74, pp. 2157 - 2164, http://dx.doi.org/10.1136/annrheumdis-2014-205577
,2015, 'Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout', Arthritis Research and Therapy, 17, http://dx.doi.org/10.1186/s13075-015-0802-3
,2015, 'Epistatic Interaction of Functional Inflammasome Genetic Variants in Determining the Risk of Gout', ARTHRITIS & RHEUMATOLOGY, 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370860204715&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, 18, pp. 1783 - 1796, http://dx.doi.org/10.1111/hex.12170
,2015, 'Identifying effective computerized strategies to prevent drug-drug interactions in hospital: A user-centered approach', International Journal of Medical Informatics, 84, pp. 595 - 600, http://dx.doi.org/10.1016/j.ijmedinf.2015.04.001
,